Maulik Majmudar

Angel investor in Baltimore

Invests in AI

Maulik Majmudar's investor profile lists AI alongside Healthcare & Biotech, Digital Health & HealthTech and Biotech & Pharma, at seed. The record holds 4 deals, among them HILABSINC, Massachusetts General Hospital and Praan.

Email Investor

Email Investor

Credits to line up before a seed round

Maulik Majmudar backs companies at seed. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • HILABSINC
  • Massachusetts General Hospital
  • Praan
  • Prevently

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma, SaaS & Enterprise, Climate & Energy and 5 more
Rounds
Seed
Profile
Angel investor
Deals on record
4
Based in
Baltimore, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Maulik Majmudar invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Maulik Majmudar's investor profile, together with Healthcare & Biotech, Digital Health & HealthTech and Biotech & Pharma. The stages on record are seed.
Which companies has Maulik Majmudar backed?
The record lists 4 deals, including HILABSINC, Massachusetts General Hospital, Praan and Prevently. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Maulik Majmudar?
For a company raising a seed round, AI Perks lists credits such as Microsoft Azure (up to $25,000), Gemini (up to $350,000), Neon (up to $100,000) and Algolia (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor